Stephen Hanauer to Patient Selection
This is a "connection" page, showing publications Stephen Hanauer has written about Patient Selection.
Connection Strength
0.750
-
Subgroups. Nat Clin Pract Gastroenterol Hepatol. 2008 Jan; 5(1):1.
Score: 0.237
-
Novel potential perils of volunteering for clinical trials. Nat Clin Pract Gastroenterol Hepatol. 2005 Aug; 2(8):337.
Score: 0.200
-
Shared experiences and best practices in the management of rheumatoid arthritis and Crohn's disease. Am J Med. 2011 Apr; 124(4 Suppl):e1-18.
Score: 0.074
-
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response? Am J Gastroenterol. 2011 Feb; 106(2):199-212; quiz 213.
Score: 0.072
-
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial. Gastroenterology. 2006 Feb; 130(2):323-33; quiz 591.
Score: 0.052
-
Top-down versus step-up approaches to chronic inflammatory bowel disease: presumed innocent or presumed guilty. Nat Clin Pract Gastroenterol Hepatol. 2005 Nov; 2(11):493.
Score: 0.051
-
Treatment of Crohn's disease: the "long" of it. Gastroenterology. 2005 Jun; 128(7):2164-6.
Score: 0.049
-
Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial. Gastroenterology. 2008 Mar; 134(3):688-95.
Score: 0.015